drugset / Trial / NCT00398502

Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone

NCT00398502

Phase 1 Completed Bausch Health Americas, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

Primary: To determine the relative bioavailability of MOA-728, an investigational drug, administered orally in both the capsule and tablet formulations to methadone maintenance subjects.Secondary: To assess the pharmacodynamic effect of MOA-728 administered both orally and subcutaneously to methadone maintenance subjects using the oral-cecal transit time.

Timeline

Start
2006-10
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified Oral

Indications

No indication recorded.